94 related articles for article (PubMed ID: 12532992)
1. [Effects of gravity on the gene expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor].
Kanematsu M; Takai H; Fujita Y; Sato A
Biol Sci Space; 1999 Sep; 13(3):140-1. PubMed ID: 12532992
[No Abstract] [Full Text] [Related]
2. [Clinostat rotation culture modulates gene expression of osteoclastogenesis-regulating factors via a cyclic-AMP dependent mechanism].
Kanematsu M; Takai H; Takaoki M; Sato A
Biol Sci Space; 2000 Oct; 14(3):266-7. PubMed ID: 12561872
[No Abstract] [Full Text] [Related]
3. [OPG(osteoprotegerin)/OCIF(osteoclastogenesis inhibitory factor)].
Inoue D
Nihon Rinsho; 2004 Feb; 62 Suppl 2():102-6. PubMed ID: 15035105
[No Abstract] [Full Text] [Related]
4. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
5. Regulation of osteoclastogenesis by gap junction communication.
Matemba SF; Lie A; Ransjö M
J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710
[TBL] [Abstract][Full Text] [Related]
6. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro].
Xiao XH; Zhou HD; Yuan LQ; Xie H; Liao EY
Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2102-6. PubMed ID: 15730627
[TBL] [Abstract][Full Text] [Related]
7. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
8. Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506.
Fukunaga J; Yamaai T; Yamachika E; Ishiwari Y; Tsujigiwa H; Sawaki K; Lee YJ; Ueno T; Kirino S; Mizukawa N; Takagi S; Nagai N; Sugahara T
Bone; 2004 Mar; 34(3):425-31. PubMed ID: 15003790
[TBL] [Abstract][Full Text] [Related]
9. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.
Ishida M; Amano S
J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862
[TBL] [Abstract][Full Text] [Related]
10. Soluble glucocorticoid-induced tumor necrosis factor receptor stimulates osteoclastogenesis by down-regulation of osteoprotegerin in bone marrow stromal cells.
Shin HH; Kim SJ; Kang SY; Lee DS; Choi HS
Bone; 2006 Oct; 39(4):716-23. PubMed ID: 16750437
[TBL] [Abstract][Full Text] [Related]
11. Osteoclast development in immobilized bone is suppressed by parathyroidectomy in mice.
Sakai A; Mori T; Sakuma-Zenke M; Takeda T; Nakai K; Katae Y; Hirasawa H; Nakamura T
J Bone Miner Metab; 2005; 23(1):8-14. PubMed ID: 15616888
[TBL] [Abstract][Full Text] [Related]
12. Chronology and regulation of gene expression of RANKL in the rat dental follicle.
Liu D; Yao S; Pan F; Wise GE
Eur J Oral Sci; 2005 Oct; 113(5):404-9. PubMed ID: 16202028
[TBL] [Abstract][Full Text] [Related]
13. IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts.
Tanabe N; Maeno M; Suzuki N; Fujisaki K; Tanaka H; Ogiso B; Ito K
Life Sci; 2005 Jun; 77(6):615-26. PubMed ID: 15921993
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
[TBL] [Abstract][Full Text] [Related]
15. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of osteoprotegerin production in bone marrow macrophages by macrophage colony-stimulating factor.
Yamada N; Tsujimura T; Ueda H; Hayashi S; Ohyama H; Okamura H; Terada N
Cytokine; 2005 Aug; 31(4):288-97. PubMed ID: 15996478
[TBL] [Abstract][Full Text] [Related]
17. Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.
Koh JM; Lee YS; Byun CH; Chang EJ; Kim H; Kim YH; Kim HH; Kim GS
J Endocrinol; 2005 Jun; 185(3):401-13. PubMed ID: 15930166
[TBL] [Abstract][Full Text] [Related]
18. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
[TBL] [Abstract][Full Text] [Related]
19. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
Lossdörfer S; Schwartz Z; Wang L; Lohmann CH; Turner JD; Wieland M; Cochran DL; Boyan BD
J Biomed Mater Res A; 2004 Sep; 70(3):361-9. PubMed ID: 15293309
[TBL] [Abstract][Full Text] [Related]
20. Bone stromal cells in pagetic bone and Paget's sarcoma express RANKL and support human osteoclast formation.
Sun SG; Lau YS; Itonaga I; Sabokbar A; Athanasou NA
J Pathol; 2006 May; 209(1):114-20. PubMed ID: 16482498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
